Status:
COMPLETED
Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria
Lead Sponsor:
Mansoura University
Conditions:
Hematuria
Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our goal is to develop a noninvasive, fast and simple assay to detect BCa on the GeneXpert system and metablomic genes.
Detailed Description
The Xpert BCa monitor is a novel mRNA-based urine test that measures five mRNA targets (ABL1, ANXA10, UPK1B, CRH, and IGF2) in urine sample by real time RT-PCR. Previous studies had investigated the f...
Eligibility Criteria
Inclusion
- Patients with gross or persistent microscopic hematuria with irritative bladder symptoms
Exclusion
- patients on anticoagulants
- patients with history of radiotherapy
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
181 Patients enrolled
Trial Details
Trial ID
NCT04317261
Start Date
March 1 2018
End Date
March 1 2020
Last Update
March 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, DK, Egypt, 35516